Promethazine hydrochloride reduces children's agitation during ocular examination for trauma

Zahra Ghiasi1, Mohammad Hosein Validad2, Shokoufeh Mogharabi Ostadkelayeh3

  • 1Department of Psychiatry and Clinical Psychology, School of Medicine, Zahedan University of Medical Sciences, Zahedan. linooshghiasi@gmail.com.

Insights

Promethazine hydrochloride effectively reduced agitation in children undergoing ocular trauma examinations. This medication significantly lowered physical and verbal aggressive behaviors, and hiding behaviors during examinations.

Area of Science:

  • Ophthalmology
  • Pediatric Medicine
  • Clinical Pharmacology

Background:

  • Pediatric ocular examinations for trauma can induce significant agitation, anxiety, and fear.
  • Effective management of agitation is crucial for successful examination and patient care.

Purpose of the Study:

  • To evaluate the efficacy of promethazine hydrochloride in mitigating agitation in pediatric patients during ocular trauma examinations.
  • To compare the effects of promethazine hydrochloride versus placebo on children's behavior during these examinations.

Main Methods:

  • An interventional clinical trial involving 62 pediatric patients with ocular trauma.
  • Patients were divided into two matched groups: case (promethazine hydrochloride) and control (placebo).
  • Promethazine hydrochloride (0.5 mg/kg) or placebo was administered 20 minutes prior to examination, with behavior assessed using a modified Cohen-Mansfield Agitation Inventory (CMAI).

Main Results:

  • Promethazine hydrochloride significantly reduced physical/aggressive behaviors (p < 0.001).
  • Significant reductions were observed in physical/nonaggressive behaviors (p = 0.013), verbal/aggressive behaviors (p < 0.001), and hiding behaviors (p < 0.001) in the promethazine group.
  • The intervention facilitated examinations for children with traumatic ocular injuries.

Conclusions:

  • Promethazine hydrochloride is effective in reducing agitation in children during ocular trauma examinations.
  • The medication aids in managing challenging behaviors, improving the examination process.
  • Further research via randomized controlled trials is recommended to confirm these findings.

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
422
Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
814
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
308
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
528
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
188
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
231